Neurobo Pharmaceuticals, Inc.
SEC CIK 1638287 · NRBO · last insider filing 2026-06-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Strickland D Gordon | Director | filed 2022 - 2026 |
| Koven Andrew I | Director | filed 2021 - 2026 |
| Glickman Mark A | Director | filed 2023 - 2026 |
| Groves Jason L | Director | filed 2019 - 2026 |
| Tursi James Patrick | Director | filed 2023 - 2026 |
| Salsbury Michael | Director | filed 2019 - 2026 |
| Kim Hyung Heon | Director · CEO & President | filed 2021 - 2026 |
| Kim Na Yeon | Director | filed 2020 - 2023 |
| Kang Richard | Director | filed 2020 - 2022 |
| Bakshi Akash | Director · SVP and COO | filed 2021 - 2021 |
| Swirsky Douglas J | Director | filed 2020 - 2020 |
| Jeong Tae Heum | Director | filed 2019 - 2020 |
| Gullans Steven R. Ph.D. | Director · President & CEO | filed 2016 - 2020 |
| Oh Jeong Gyun | Director | filed 2020 - 2020 |
| Bisgaier Charles PhD | Director · Chief Scientific Off. & Chair | filed 2016 - 2019 |
| Lichtinger Pedro | Director | filed 2016 - 2019 |
| Sassine Andy | Director | filed 2016 - 2019 |
| Kousky Kenneth W | Director | filed 2016 - 2019 |
| Hawryluk P. Kent | Director | filed 2016 - 2018 |
| Sooch Mina | Director · President, CEO & Treasurer | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Woodworth Marshall H | Chief Financial Officer | filed 2023 - 2026 |
| Hooker Joseph | Interim CEO and President | filed 2023 - 2023 |
| Price Ben Gil | CEO and President | filed 2021 - 2021 |
| Versavel Mark | Chief Medical Officer | filed 2019 - 2020 |
| Shannon Nicola | VP, Clinical Operations | filed 2019 - 2019 |
| Reno Seth | Chief Commercial Officer | filed 2016 - 2019 |
| Mathiesen Jeffrey S | Chief Financial Officer | filed 2016 - 2018 |
| Golden Lee Scott | Chief Medical Officer | filed 2016 - 2018 |
| Oniciu Carmen Daniela | Vice President | filed 2016 - 2016 |
| Lowenschuss David | Chief Legal Off. & Secretary | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.